Study: Vitamin E may slow decline from Alzheimer disease
“Effect of Vitamin E and memantine on functional decline in Alzheimer disease,” a study published in JAMA, reports that 2,000 units of vitamin E,…
Web Exclusives
Study: Head trauma associated with Alzheimer disease changes
A study published in Neurology has found that among patients with mild cognitive impairment, self-reported head trauma with at least momentary loss of consciousness…
Study: 8 million lives saved during years since Surgeon General Report on smoking
In the 50 years since the first Surgeon General Report on smoking (in 1964) 8 million premature deaths have been avoided, according to a…
Quality-improvement initiative: Classifying and documenting surgical wounds
Interprofessional collaboration promoted a successful initiative to improve wound classification.
ANCC Announces Craig Luzinski, MSN, RN, NEA-BC, FACHE, as Director of the Magnet Recognition Program®
The American Nurses Credentialing Center (ANCC) is thrilled to name Craig J. Luzinski, MSN, RN, NEA-BC, FACHE as the new director of its internationally…
FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in…
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts that form…
FDA approves first generic versions of Cymbalta
On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.
Study: Low vitamin B12 increases fracture risk in older men
A study published in Osteoporosis International reports that older men who have low levels of vitamin B12 have a higher risk of fractures. Read…
FDA issues safety communication for HeartStart AEDs
On Nov. 25, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that certain HeartStart automated external defibrillator (AED) devices made…
FDA approves medical device for epilepsy
The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who have not…
C-suite executives believe ACA will improve health care
A survey of 74 C-suite executives published in Health Affairs finds they are optimistic about the effects of the Affordable Care Act (ACA). The…
Study: Vitamin E may slow decline from Alzheimer disease
“Effect of Vitamin E and memantine on functional decline in Alzheimer disease,” a study published in JAMA, reports that 2,000 units of…
Study: Head trauma associated with Alzheimer disease changes
A study published in Neurology has found that among patients with mild cognitive impairment, self-reported head trauma with at least momentary loss…
Study: 8 million lives saved during years since Surgeon General Report on smoking
In the 50 years since the first Surgeon General Report on smoking (in 1964) 8 million premature deaths have been avoided, according…
Quality-improvement initiative: Classifying and documenting surgical wounds
Interprofessional collaboration promoted a successful initiative to improve wound classification.
ANCC Announces Craig Luzinski, MSN, RN, NEA-BC, FACHE, as Director of the Magnet Recognition Program®
The American Nurses Credentialing Center (ANCC) is thrilled to name Craig J. Luzinski, MSN, RN, NEA-BC, FACHE as the new director of…
FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for…
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts…
FDA approves first generic versions of Cymbalta
On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.
Study: Low vitamin B12 increases fracture risk in older men
A study published in Osteoporosis International reports that older men who have low levels of vitamin B12 have a higher risk of…
FDA issues safety communication for HeartStart AEDs
On Nov. 25, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that certain HeartStart automated external defibrillator (AED)…
FDA approves medical device for epilepsy
The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who…
C-suite executives believe ACA will improve health care
A survey of 74 C-suite executives published in Health Affairs finds they are optimistic about the effects of the Affordable Care Act…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.